A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.

Millstein, Joshua; Budden, Timothy; Anglesio, Michael; Talhouk, Aline; Beeghly-Fadiel, Alicia; Berchuck, Andrew; Chenevix-Trench, Georgia; deFazio, Anna; Fasching, Peter A; Gayther, Simon; Garcia, Maria; Goode, Ellen L; Henderson, Michelle; Konecny, Gottfried E; Orsulic, Sandra; Huntsman, David; Bowtell, David; Doherty, Jennifer; Pharoah, Paul; Ramus, Susan J

View / Open Files

Accepted version (PDF, 1Mb)

Authors

Millstein, Joshua

Budden, Timothy

Anglesio, Michael

Talhouk, Aline

Beeghly-Fadiel, Alicia

Berchuck, Andrew

Chenevix-Trench, Georgia

Publication Date

2018-05-20

Journal Title

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Volume

Issue

Type

Conference Object

This Version

Metadata

Show full item record

Citation

Millstein, J., Budden, T., Anglesio, M., Talhouk, A., Beeghly-Fadiel, A., Berchuck, A., Chenevix-Trench, G., et al. (2018). A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.. JOURNAL OF CLINICAL ONCOLOGY, 36 (15)https://doi.org/10.1200/JCO.2018.36.15_suppl.5583

Sponsorship

Cancer Research UK (16561)

National Institutes of Health (NIH) (via H Lee Moffitt Cancer Center & Research Institute) (SUBAWARD # 10-15915-01-03-G2)

Congressionally Directed Medical Research Programs (CDMRP) (via (BD521555)

National Institutes of Health (NIH) (via Cedars-Sinai Medical Center) (sub award 0001331845)

H. Lee Moffitt Cancer Center & Research Institute (8604)

Identifiers

External DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.5583

This record's URL: https://www.repository.cam.ac.uk/handle/1810/315175